angioClast
Cambridge
About angioClast
angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Mar 2016)
- Website: angioclast.co.uk
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/angioclast-3425059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.